243 related articles for article (PubMed ID: 38065623)
1. Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors.
Cao J; Chen Q; Bai X; Liu L; Ma W; Lin C; Lu F; Zhou T; Zhan J; Huang Y; Yang Y; Luo F; Zhao H
Ann Med; 2023; 55(2):2280002. PubMed ID: 38065623
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
3. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.
Zeng X; Liu G; Pan Y; Li Y
J Cell Mol Med; 2020 Aug; 24(15):8326-8349. PubMed ID: 32603520
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma.
Ye M; Huang A; Yuan B; Tan G; Ai J; Liu H
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1971-1989. PubMed ID: 38315178
[TBL] [Abstract][Full Text] [Related]
7. Reference intervals of systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio during normal pregnancy in China.
Bai YY; Xi Y; Yin BB; Zhang JH; Chen F; Zhu B
Eur Rev Med Pharmacol Sci; 2023 Feb; 27(3):1033-1044. PubMed ID: 36808350
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
9. Inflammation-based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy.
Chen T; Tang M; Xu X; Liang G; Xiang Z; Lu Y; Wang C; Shen W
J Clin Lab Anal; 2022 Dec; 36(12):e24772. PubMed ID: 36441595
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of inflammation-based indexes in patients with stage III/IV colorectal cancer after adjuvant chemoradiotherapy.
Yang J; Guo X; Wu T; Niu K; Ma X
Medicine (Baltimore); 2019 Feb; 98(6):e14420. PubMed ID: 30732196
[TBL] [Abstract][Full Text] [Related]
11. Study on the predictive value of pretreatment peripheral blood inflammatory markers regarding immunotherapy in patients with inoperable advanced or locally advanced oesophageal squamous cell carcinoma.
Fu M; Li Z; Ma J; Shen F; Zhang X
Scand J Gastroenterol; 2024 Jun; 59(6):722-729. PubMed ID: 38362884
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era.
Li Q; Yu L; Yang P; Hu Q
Cancer Manag Res; 2021; 13():6799-6810. PubMed ID: 34512020
[TBL] [Abstract][Full Text] [Related]
13. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
14. The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors.
Liu N; Mao J; Tao P; Chi H; Jia W; Dong C
Medicine (Baltimore); 2022 Jan; 101(3):e28617. PubMed ID: 35060536
[TBL] [Abstract][Full Text] [Related]
15. Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
Zhang X; Gari A; Li M; Chen J; Qu C; Zhang L; Chen J
J Transl Med; 2022 Feb; 20(1):61. PubMed ID: 35109887
[TBL] [Abstract][Full Text] [Related]
16. Combined pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts survival and prognosis in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.
Yang D; Li P; Meng Z; Hu X; Huang Z; Huang H; Dong H; Qin Y; Chen C; Chen X; Li Z; Zhou Z; Li Y; Kang M
Sci Rep; 2024 Apr; 14(1):9898. PubMed ID: 38688967
[TBL] [Abstract][Full Text] [Related]
17. Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study.
Zheng F; Meng Q; Zhang L; Chen J; Zhao L; Zhou Z; Liu Y
World J Surg Oncol; 2023 Jul; 21(1):198. PubMed ID: 37420219
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Reference Intervals for SII, NLR, PLR, and LMR in Healthy Adults in Jiangsu Region in Eastern China.
Liu Q; Xu A; Hang H; Chen X; Dai Y; Wang M; Yang F
Clin Lab; 2023 May; 69(5):. PubMed ID: 37145057
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer.
Yang J; Deng M; Bi M; Wang Y; Qiao X; Zhang S
Future Sci OA; 2022 Mar; 8(5):FSO798. PubMed ID: 35662746
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Pretreatment Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio in the Survival of Nasopharyngeal Carcinoma Patients.
Chen Y; Sun J; Hu D; Zhang J; Xu Y; Feng H; Chen Z; Luo Y; Lou Y; Wu H
Cancer Manag Res; 2021; 13():8767-8779. PubMed ID: 34866938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
